Taxane combined with lobaplatin or anthracycline for neoadjuvant treatment of triple-negative breast cancer: A single-center, randomized, controlled, phase-II clinical study. This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results